SEC Form D private-offering filing

Cardiol Therapeutics Inc.

Name: Cardiol Therapeutics Inc. - new SEC Form D private-offering filing, Oakville, ON, Canada
Published: 2025-11-04

A new SEC Form D private-offering notice from Oakville, ON, Canada, a $8,471,875 filer-stated offering target in Biotech. The source filing is one click away.

Cardiol Therapeutics Inc. site↗ Verified via SEC Form D

Clinical-stage life sciences company developing cannabidiol-based CardiolRx and related therapies to treat inflammatory heart conditions such as pericarditis, myocarditis, and heart failure.

Filed 2025-11-04Filed to raise $8,471,875First money in 2025-10-17Raised so far $760,000HQ (as filed) Oakville, ON, CanadaSector Biotech ✓Stage (inferred) EarlyCall status Needs classification

Source linked the Form D on EDGAR↗Website verified cardiolrx.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.